Records containing: Refractory Chronic Lymphocytic Leukemia

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2014-05-01
A Phase I Study of Obatoclax (Pan Anti-Apoptotic BCL-2 Family Small Molecule Inhibitor), in Combination With Vincristine/Doxorubicin/Dexrazoxane, in Children With Relapsed/Refractory Solid Tumors or Leukemia
CLINICAL_TRIALS study record update · 2014-04-29
A Phase I Study of MK-2206, an AKT Inhibitor, in Pediatric Patients With Recurrent or Refractory Solid Tumors or Leukemia
CLINICAL_TRIALS study record update · 2014-04-10
A Phase II Study of BAY 43-9006 in Relapsed Chronic Lymphocytic Leukemia
CLINICAL_TRIALS study record update · 2014-04-02
A Preliminary Study to Evaluate the Effects of Palifermin in Patients at Risk of Chronic Graft-versus-host Disease
CLINICAL_TRIALS study record update · 2014-03-17
A Phase 1/Pharmacokinetic Study of Sunitinib in Patients With Cancer Who Also Have HIV and Are on HAART Therapy
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2014-02-24
A Phase I Trial of the Combination of Oxaliplatin (NSC 266046, IND 57004), Ifosfamide, and Etoposide in Recurrent or Refractory Pediatric Solid Tumors and Lymphomas
CLINICAL_TRIALS study record update · 2014-02-11
A Phase II Study of CCI-779 in B-cell Lymphoma and CLL
CLINICAL_TRIALS study record update · 2014-02-10
A Phase II Study of Sunitinib Malate for Treatment of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
CLINICAL_TRIALS study record update · 2014-01-13
Phase I Clinical Trial of Neem Leaf Extract for the Treatment of Chronic Lymphocytic Leukemia
CLINICAL_TRIALS study record update · 2013-10-08
A Phase II Trial of Thalidomide in Patients With Relapsed Chronic Lymphocytic Leukemia
CLINICAL_TRIALS study record update · 2013-09-30
A Phase I Study of Decitabine in Combination With Valproic Acid in Patients With Selected Hematologic Malignancies
CLINICAL_TRIALS study record update · 2013-09-30
A Phase I Trial of PS-341 and Fludarabine for Relapsed and Refractory Indolent Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
CLINICAL_TRIALS study record update · 2013-09-30
A Phase I Study of SJG-136 in Patients With Advanced Leukemia
CLINICAL_TRIALS study record update · 2013-09-30
A Phase 1 Study of Obatoclax Mesylate (GX15-070MS) in Combination With Fludarabine-Based Chemoimmunotherapy in Previously Treated Patients With B-Cell Chronic Lymphocytic Leukemia (B-CLL)
CLINICAL_TRIALS study record update · 2013-08-22
A Phase I Trial of Bendamustine Plus Alemtuzumab for the Treatment of Fludarabine Refractory Chronic Lymphocytic Leukemia
CLINICAL_TRIALS study record update · 2013-07-16
A Phase II Study of Thrice Weekly Apolizumab in Patients With Chronic Lymphocytic Leukemia : CRC Master Protocol
CLINICAL_TRIALS study record update · 2013-06-06
Randomized Phase II Study of Thalidomide Versus Thalidomide Plus Fludarabine for Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine
CLINICAL_TRIALS study record update · 2013-06-04
A Phase I Study of PS-341 (Velcade, Bortezomib) in Combination With 17-allylamino-17-demethoxygeldanamycin (17-AAG) in Patients With Relapsed or Refractory Hematologic Malignancies
CLINICAL_TRIALS study record update · 2013-06-04
A Phase 1 Study of 17-allylamino-17-demethoxygeldanamycin (17-AAG) (NSC 330507; IND 57,966) and Rituximab in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia (CLL)
CLINICAL_TRIALS study record update · 2013-06-04
Phase I Study of Thrice Weekly Hu1D10*in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Acute Leukemia
CLINICAL_TRIALS study record update · 2013-06-04
A Phase I Study of Flavopiridol, Fludarabine and Rituximab in Indolent B-cell Lymphoproliferative Disorders and Mantle Cell Lymphoma
CLINICAL_TRIALS study record update · 2013-05-14
A Phase II Trial of Bevacizumab to Prevent or Delay Disease Progression in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
CLINICAL_TRIALS study record update · 2013-03-27
CTLA-4 Blockade With MDX-010 to Induce Graft-Versus-Malignancy Effects Following Allogeneic Hematopoietic Stem Cell Transplantation
CLINICAL_TRIALS study record update · 2013-03-19
A Phase I Study of the Raf Kinase/VEGFR Inhibitor BAY 43-9006 in Combination With the Proteasome Inhibitor PS-341 in Patients With Advanced Malignancies
CLINICAL_TRIALS study record update · 2013-02-08
A Phase I Study of XK469R (NSC 698215) in Patients With Refractory Hematologic Malignancies